BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18565396)

  • 1. The "vulnerable" stent why so dreadful?
    Alfonso F
    J Am Coll Cardiol; 2008 Jun; 51(25):2403-6. PubMed ID: 18565396
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug eluting or bare metal stent for acute myocardial infarction: an issue of safety?
    Finn AV; Nakazawa G; Kolodgie F; Virmani R
    Eur Heart J; 2009 Aug; 30(15):1828-30. PubMed ID: 19515688
    [No Abstract]   [Full Text] [Related]  

  • 3. Multivessel disease in diabetics: does DES level the field?
    Hillegass W
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):881-2. PubMed ID: 19455651
    [No Abstract]   [Full Text] [Related]  

  • 4. The balance of risks and benefits of drug-eluting versus bare-metal stents.
    Pfisterer M; Brunner-La Rocca HP; Kaiser C
    J Am Coll Cardiol; 2008 Mar; 51(9):972; author reply 972-3. PubMed ID: 18308171
    [No Abstract]   [Full Text] [Related]  

  • 5. The safety of drug-eluting stents.
    Saia F; Marzocchi A; Branzi A
    Ther Adv Cardiovasc Dis; 2008 Feb; 2(1):43-52. PubMed ID: 19124407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ST-elevated acute myocardial infarction happening 1 month post stent implantation: late thrombosis in-stents or new lesions?
    Song GY; Yang YJ; Xu B; Li JJ; Gao RL; Qiao SB; Yuan JQ; Tang YD; You SJ; Pei HJ; Zhao ZY; Wang XM; Wu YJ
    Chin Med J (Engl); 2009 Jul; 122(14):1610-4. PubMed ID: 19719959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composition of thrombi in late drug-eluting stent thrombosis versus de novo acute myocardial infarction.
    Nishihira K; Yamashita A; Ishikawa T; Hatakeyama K; Shibata Y; Asada Y
    Thromb Res; 2010 Sep; 126(3):254-7. PubMed ID: 19942261
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus.
    Maeng M; Jensen LO; Kaltoft A; Hansen HH; Bøttcher M; Lassen JF; Thayssen P; Krusell LR; Rasmussen K; Pedersen L; Sørensen HT; Johnsen SP; Thuesen L
    Am J Cardiol; 2008 Jul; 102(2):165-72. PubMed ID: 18602515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the OPTIMIST study.
    Burzotta F; Parma A; Pristipino C; Manzoli A; Belloni F; Sardella G; Rigattieri S; Danesi A; Mazzarotto P; Summaria F; Romagnoli E; Prati F; Trani C; Crea F
    Eur Heart J; 2008 Dec; 29(24):3011-21. PubMed ID: 18987096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
    Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M
    Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study.
    Wenaweser P; Daemen J; Zwahlen M; van Domburg R; Jüni P; Vaina S; Hellige G; Tsuchida K; Morger C; Boersma E; Kukreja N; Meier B; Serruys PW; Windecker S
    J Am Coll Cardiol; 2008 Sep; 52(14):1134-40. PubMed ID: 18804739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
    Roy P; Bonello L; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Mar; 103(6):801-5. PubMed ID: 19268735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent late drug-eluting stent thrombosis upon discontinuation of antiplatelet therapy.
    Varghese I; Ummer A; Roesle M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2008; 9(3):179-81. PubMed ID: 18606381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late stent thrombosis or Kounis syndrome?
    Horjeti B; Meco S
    Int J Cardiol; 2011 Jul; 150(2):e70-2. PubMed ID: 19914724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-stent technique: a dead duck or alive and kicking?
    Belardi JA
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):321-2. PubMed ID: 19642180
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-eluting stents are safe.
    Garg S; Serruys P
    Clin Pharmacol Ther; 2009 Aug; 86(2):130-2. PubMed ID: 19621006
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases.
    van Werkum JW; Heestermans AA; de Korte FI; Kelder JC; Suttorp MJ; Rensing BJ; Zwart B; Brueren BR; Koolen JJ; Dambrink JH; van't Hof AW; Verheugt FW; ten Berg JM
    Circulation; 2009 Feb; 119(6):828-34. PubMed ID: 19188507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.
    van Werkum JW; Heestermans AA; Zomer AC; Kelder JC; Suttorp MJ; Rensing BJ; Koolen JJ; Brueren BR; Dambrink JH; Hautvast RW; Verheugt FW; ten Berg JM
    J Am Coll Cardiol; 2009 Apr; 53(16):1399-409. PubMed ID: 19371823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.